Alector
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
131 Oyster Point Blvd Ste 600, South San...Phone Number
(415) 231-5660Website
www.alector.comRevenue
$13.9 MillionStock Symbol
ALECIndustry
About Alector
Alector Therapeutics is a biopharmaceutical company focused on developing therapies for neurodegenerative diseases. Utilizing their proprietary Alector Brain Carrier (ABC) technology, they aim to deliver treatments across the blood-brain barrier, enhancing efficacy and administration convenience. Their mission is to address unmet needs in neurodegeneration, with a vision of preventing these diseases altogether. Alector's diverse pipeline is grounded in rigorous science and aims to make a meaningful impact on the lives of patients suffering from conditions like Amyotrophic Lateral Sclerosis (ALS) and Parkinson's disease.Explore more
Alector Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Alector
Compare insights from companies similar to Alector, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Alector Tech Stack
A closer look at the technologies used by Alector
See more technologies
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Alector
Sign Up For FreeTo access detailed company insights
Alector Therapeutics is a biopharmaceutical company focused on developing therapies for neurodegenerative diseases. Utilizing their proprietary Alector Brain Carrier (ABC) technology, they aim to deliver treatments across the blood-brain barrier, enhancing efficacy and administration convenience. Their mission is to address unmet needs in neurodege... Read More
